International journal of surgery case reports · 2025
Male breast cancer following complete remission of acute myeloid leukemia: A case report and literature review.
Клинический случайСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qiao Weiqiang, Li Peng, Chang Chang, Fan Mengnan, Deng Miao
Аннотация
INTRODUCTION: Male breast cancer (MBC) is a rare clinical entity. The concurrent development of MBC and leukemia is particularly rare.
PRESENTATION OF CASE: A 51-year-old male patient developed MBC following a 14-year complete remission of acute myeloid leukemia (AML). The patient underwent neoadjuvant chemotherapy, followed by surgical resection and adjuvant radiotherapy, and is currently receiving endocrine therapy with tamoxifen (10 mg twice daily, orally), with favorable outcomes observed during recent follow-up evaluations.
DISCUSSION: MBC is predominantly diagnosed as locally advanced disease. Reported cases include MBC following acute lymphoblastic leukemia (ALL) and therapy-related AML post-chemotherapy for female breast cancer, whereas our case exhibits novel distinctions compared to prior reports.
CONCLUSION: This case report describes the first documented occurrence of MBC in a patient who achieved complete remission from AML, offering valuable insights for the clinical management of analogous cases in the future.
PRESENTATION OF CASE: A 51-year-old male patient developed MBC following a 14-year complete remission of acute myeloid leukemia (AML). The patient underwent neoadjuvant chemotherapy, followed by surgical resection and adjuvant radiotherapy, and is currently receiving endocrine therapy with tamoxifen (10 mg twice daily, orally), with favorable outcomes observed during recent follow-up evaluations.
DISCUSSION: MBC is predominantly diagnosed as locally advanced disease. Reported cases include MBC following acute lymphoblastic leukemia (ALL) and therapy-related AML post-chemotherapy for female breast cancer, whereas our case exhibits novel distinctions compared to prior reports.
CONCLUSION: This case report describes the first documented occurrence of MBC in a patient who achieved complete remission from AML, offering valuable insights for the clinical management of analogous cases in the future.